ARCHIVES

In Brief: UC Irvine Wins Grant For Trial Of One-Visit Cervical Cancer Screening, Treatment

This article is from The Cancer Letter archive.

Vol. 24 No. 42 | November 6, 1998

Download PDF Visit The Full Archive

Related Articles

FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint.

July 21, 2006

Ibrutinib Demonstrates 71% ORR In Phase Ib/II CLL and SLL Study

July 26, 2013

New Safety Concerns On ESAs Prompt FDA To Consult ODAC Again.

January 11, 2008

Michael Link Elected ASCO President.

January 15, 2010

News Organizations Protest invitation-Only Press Conferences, Exclusion of Reporters

May 20, 1994

Herberman Leaving NCI To Head New Pittsburgh Institute

July 12, 1985